Search for ""
NO results found.
- C3a-Receptor monoclonal antibodies from University of Goettingen
C3a are known to trigger mast cell degranulation (Anaphylatoxin)
- New preclinical stage prostate cancer drug inhibits prostate tumor growth and metastasis in a different mode of action than current anti-cancer drugs
inhibits human prostate cancer cell metastasis as efficiently as combretastatin
- Merck KGaA is looking for a broad range of analytic, drug delivery and stem cell products and technologies
Antibodies, Biomarker assays, Drug Delivery Compounds and methods, Tools for stem cell research
- Sanofi Pasteur is seeking opportunities in vaccines, antibodies and supporting technologies for prevention of treatment of infectious diseases
novel antigens, carrier proteins, adjuvants, vaccine vectors, basic immunology, fermentor and bioreactor technology, preservatives and stabilizers, biological markers, epidemiological studies
- Morphinan-6-ones for the treatment of neurodegenerative diseases
compounds exhibit pro-cholinergic properties but avoid opioid receptor agonism
© 2006-2007
by Herbert-Worch-Foundation
print this page
